From Nasdaq: 2025-04-11 04:25:00

Microsoft and Johnson & Johnson are leading companies with impressive track records, making their long-term shareholders richer. Despite concerns about investing in these giants, Microsoft’s $2.6 trillion market cap and Johnson & Johnson’s talc-related lawsuits are challenges to consider.

Microsoft faces potential challenges with tariffs affecting production costs, but its strong cash flow and brand name provide resilience. The company’s cloud division, Azure, shows significant growth potential with AI, boasting an annual run rate of over $13 billion.

Johnson & Johnson, spared from tariffs so far, faces ongoing talc-related lawsuits that have not been resolved. Despite legal troubles, J&J’s operations remain strong, with a robust balance sheet, steady revenue, and a history of important breakthroughs.

Investors should consider Microsoft’s growth prospects in cloud computing and AI, along with its secure dividend program. Meanwhile, Johnson & Johnson’s pharmaceutical and medtech businesses, coupled with its Dividend King status, make it an attractive long-term investment option.



Read more at Nasdaq: 2 Top Dividend Stocks to Buy Right Now